fda approves generic glp 1 New GLP-1 Pill Foundayo (Orforglipron) Gets Approval for Obesity This Week in GLP-1: A

Exendin-4 is a long-acting potent agonist of the glucagon-like peptide 1 (GLP-1)

This medication may support weight loss by: Reducing hunger signals Increasing feelings of fullness Supporting blood sugar and metabolic regulation Because tirzepatide works on two hormone pathways instead of one, some patients experience stronger appetite suppression or more significant weight loss results

Fundamentals of Toxicology: Essential Concepts and Applications

Though not identical, Ozempic interacts with the same receptors, providing similar benefits such as improved blood sugar control, slowed digestion, and reduced appetite

Semaglutide and tirzepatide slow down digestion, which makes it more likely that someone would aspirate when they are sedated